Patent · US Active

Bispecific single chain Fv antibody molecules and methods of use thereof

US8329873B2 · kind B2 · utility

19Cited by
25References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 20, 2007
Grant dateDec 11, 2012
Priority date
Expiry dateFeb 24, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.